tradingkey.logo

IQVIA Holdings Inc

IQV
View Detailed Chart

154.930USD

+1.480+0.96%
Close 04/30, 16:00ETQuotes delayed by 15 min
27.28BMarket Cap
19.87P/E TTM

IQVIA Holdings Inc

154.930

+1.480+0.96%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.96%

5 Days

+5.35%

1 Month

-16.44%

6 Months

-24.73%

Year to Date

-21.16%

1 Year

-33.15%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 26 analysts
BUY
Current Rating
214.873
Target Price
40.03%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

561
Total
5
Median
6
Average
Company name
Ratings
Analysts
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
29
Regeneron Pharmaceuticals Inc
REGN
28
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
27
Moderna Inc
MRNA
27
1
2
3
...
112

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(2)
Buy(5)
Indicators
Sell(1)
Neutral(2)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
3.878
Neutral
RSI(14)
43.702
Neutral
STOCH(KDJ)(9,3,3)
84.110
Buy
ATR(14)
7.583
Low Volatility
CCI(14)
103.739
Buy
Williams %R
19.484
Overbought
TRIX(12,20)
-0.932
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
150.320
Buy
MA10
147.793
Buy
MA20
152.008
Buy
MA50
177.499
Sell
MA100
188.778
Sell
MA200
209.836
Sell

News

More news coming soon, stay tuned...

Company

IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Company codeIQV
CompanyIQVIA Holdings Inc
CEOMr. Ari Bousbib
Websitehttps://ir.iqvia.com/